MENU
DMAC
AS OF
Nov 14, 04:59 PM (EDT)
Price
$5.92
Change
+$0.51 (+9.41%)
Capitalization
282.26M
137 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
DMAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

DiaMedica Therapeutics (DMAC) Earnings Date & Reports

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

DMAC is expected to report earnings to fall 1.94% to -16 cents per share on March 31

DiaMedica Therapeutics DMAC Stock Earnings Reports
Q4'25
Est.
$-0.17
Q3'25
Est.
$-0.17
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.01
The last earnings report on November 12 showed earnings per share of -17 cents, meeting the estimate of -17 cents. With 390.67K shares outstanding, the current market capitalization sits at 282.26M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
DMAC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DMAC showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for DMAC
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
19
Web
https://www.diamedica.com